Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EHA 2017 | Amyloidosis: patient fitness determines therapeutic strategies

Giampaolo Merlini, MD from Scientific Institute Policlinico San Matteo, University of Pavia, Pavia, Italy provides an overview of amyloidosis treatment for different subsets of patients depending on levels of ‘fitness’. He outlines different modes of therapy including stem cell transplantation, chemotherapy and combined therapy including pomalidomide and dexamethasone which shows promising results. Recorded at the European Hematological Association (EHA) 2017 in Madrid, Spain.